DEPARTMENT OF OPTOMETRY
Jimmy D. Bartlett, O.D., D.O.S., Sc.D.
Professor, Optometry
Department Chair
Contact Information:
Academic Office - (205) 934-3036
Patient Services/Appointments:
UOG Faculty Practice - (205) 934-5161
Physical Address:
522 Henry Peters Building
1716 University Boulevard
Mailing Address:
HPB 522
1530 Third Avenue South
Birmingham, AL 35294-0010
Biographical Sketch:
Education:
1972, B.S., Southern College of Optometry, Memphis, Tennessee
1974, O.D., Southern College of Optometry, Memphis, Tennessee
1986, D.O.S. (Honoris causa), Southern College of Optometry, Memphis, Tennessee
2002, Sc.D. (Honoris causa), State University of New York, New York City
Administrative Responsibilities:
Chairman, Department of Optometry
Director of the Professional Program in Optometry
Secondary Appointments:
Professor, Department of Pharmacology and Toxicology, School of Medicine
Scholarly Activity:
Teaching:
OPT 233 Ocular Pharmacology. This 40 clock-hour course is taught in the spring quarter of the second professional year and considers the classification and pharmacologic actions of currently employed ophthalmic drugs. Emphasis is placed on the clinical utilization of these drugs including indications, contraindications, dosages, and side effects, for the diagnosis and management of ocular disorders. Special emphasis is placed on medications used routinely for the delivery of primary eye care.
Learning Objectives:
At the conclusion of this course, students should understand:
- The basic science of ocular pharmacology
- Clinical administration of ocular drugs, including routes of administration, legal and regulatory issues, and prescription writing
- Drugs affecting the autonomic nervous system for use in pupillary dilation and cycloplegic refraction
- Drugs used principally for treatment of glaucoma
- Legal aspects of drug utilization
- Clinical selection and uses of anti-inflammatory drugs
- Uses of local anesthetics, both topical and injectable
- Contemporary aspects of nutritional pharmacology
- Uses of medications for treatment of ocular allergy
- Uses of medications to treat ocular infections
- Ophthalmic dyes, both topical and injected, including photodynamic therapy
- Lubricant preparations and tear stimulants for treatment of dry eye
- The ocular effects of systemic drugs
Research:
Special clinical and research interests lie in ocular pharmacology and investigational drugs, with emphasis in external eye disease and glaucoma.
Recent Publications:
Evans DW, Hosking SL, Gherghel D, Bartlett JD. Contrast sensitivity improves after brimonidine therapy in primary open-angle glaucoma. Br J Ophthalmol 2003; 87:1463-14
Karpecki P, Bartlett JD, Bloomenstein M, et al. New advances in combination corticosteroid/anti-infective therapy for the management of acute and chronic ocular disease. Optom Manage 2005 (suppl) 40 (3): 1-43.
Semes L, Shaikh A, McGwin G, Bartlett JD. The relationship among race, iris color, central corneal thickness, and intraocular pressure. Optom Vis Sci 2006; 83: 512-515
Bartlett JD, Fiscella RG, Bennett E, et.al., eds. Ophthalmic Drug Facts, 18th edition, St. Louis: Wolters Kluwer Health/Facts and Comparisons, 2007
Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmacology, 5th ed. St. Louis: Elsevier, 2008